(Q39841127)

15 September 2017

title

α-synuclein genetic variability: A biomarker for dementia in Parkinson disease (English)

1 reference

15 September 2017

0 references

0 references

1 reference

1 reference

10

1 reference

15 September 2017

14

1 reference

15 September 2017

11

Owen A Ross

1 reference

15 September 2017

John Dalrymple-Alford

8

object named as

John C Dalrymple-Alford

1 reference

15 September 2017

Ilaria Guella

1

1 reference

15 September 2017

Daniel M Evans

2

1 reference

15 September 2017

Chelsea Szu-Tu

3

1 reference

15 September 2017

Ekaterina Nosova

4

1 reference

15 September 2017

Stephanie F Bortnick

5

1 reference

15 September 2017

SNCA Cognition Study Group

6

1 reference

15 September 2017

Jennifer G Goldman

7

1 reference

15 September 2017

Gert J Geurtsen

9

1 reference

15 September 2017

Lefkos T Middleton

12

1 reference

15 September 2017

Laura Parkkinen

13

1 reference

15 September 2017

publication date

18 April 2016

1 reference

15 September 2017

1 reference

15 September 2017

volume

79

1 reference

15 September 2017

issue

6

1 reference

15 September 2017

page(s)

991-999

1 reference

Cognitive profile of patients with newly diagnosed Parkinson disease.

15 September 2017

cites work

1 reference

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

21 January 2018

1 reference

Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

21 January 2018

1 reference

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years

21 January 2018

1 reference

Association between cognition and function in patients with Parkinson disease with and without dementia

21 January 2018

1 reference

Clinical diagnostic criteria for dementia associated with Parkinson's disease

21 January 2018

1 reference

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers

21 January 2018

1 reference

Differences in neuropathologic characteristics across the Lewy body dementia spectrum

21 January 2018

1 reference

Relationship between Parkinson disease with dementia and dementia with Lewy bodies

21 January 2018

1 reference

Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias

21 January 2018

1 reference

Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases

21 January 2018

1 reference

The neuropathology of genetic Parkinson's disease

21 January 2018

1 reference

Diagnostic criteria for Parkinson disease

21 January 2018

1 reference

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

The MoCA: well-suited screen for cognitive impairment in Parkinson disease.

21 January 2018

1 reference

Predictors of cognitive impairment in an early stage Parkinson's disease cohort

21 January 2018

1 reference

SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies.

21 January 2018

1 reference

Defining neurodegeneration on Guam by targeted genomic sequencing.

21 January 2018

1 reference

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

21 January 2018

1 reference

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

The Sequence Alignment/Map format and SAMtools

21 January 2018

1 reference

PLINK: a tool set for whole-genome association and population-based linkage analyses

21 January 2018

1 reference

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

21 January 2018

1 reference

Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease

21 January 2018

1 reference

SNCA variant associated with Parkinson disease and plasma alpha-synuclein level

21 January 2018

1 reference

Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.

21 January 2018

1 reference

Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease

21 January 2018

1 reference

Histone modifications at human enhancers reflect global cell-type-specific gene expression

21 January 2018

1 reference

Abundant contribution of short tandem repeats to gene expression variation in humans

21 January 2018

1 reference

Alpha- and beta-synuclein expression in Parkinson disease with and without dementia

21 January 2018

1 reference

Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients

21 January 2018

1 reference

Alteration in alpha-synuclein mRNA expression in Parkinson's disease

21 January 2018

1 reference

Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease

21 January 2018

1 reference

Genetic variability in the SNCA gene influences α-synuclein levels in the blood and brain

21 January 2018

1 reference

Genetic regulation of alpha-synuclein mRNA expression in various human brain tissues

21 January 2018

1 reference

A single nucleotide polymorphism in the 3'UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease

21 January 2018

1 reference

A cytosine-thymine (CT)-rich haplotype in intron 4 of SNCA confers risk for Lewy body pathology in Alzheimer's disease and affects SNCA expression.

21 January 2018

1 reference

Relationships between age and late progression of Parkinson's disease: a clinico-pathological study

21 January 2018

1 reference

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

21 January 2018

1 reference

Motor impairment in PD: relationship to incident dementia and age.

21 January 2018

1 reference

Unbiased approaches to biomarker discovery in neurodegenerative diseases

21 January 2018

1 reference

The Parkinson Progression Marker Initiative (PPMI).

21 January 2018

1 reference

Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease

21 January 2018

1 reference

-Synuclein and Parkinson disease susceptibility

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.24664

1 reference

15 September 2017

1 reference